Cognyte Software (CGNT)
Turns complex data into actionable intelligence for public-safety and security users.
$8.72
vs last close+0.09 (+0.98%)
In millions of USD, except per-share figures
| In millions | Q3 FY24Oct 2023 | Q4 FY24Jan 2024 | Q1 FY25Apr 2024 | Q2 FY25Jul 2024 | Q3 FY25Oct 2024 | Q4 FY25Jan 2025 | Q1 FY26Apr 2025 | Q2 FY26Jul 2025 | Q3 FY26Oct 2025 | Q4 FY26Jan 2026 | Q1 FY27Apr 2026 | Q2 FY27Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 79 | 84 | 83 | 84 | 89 | 95 | 96 | 98 | 101 | 106 | 105 | 109 |
| Cost of revenue | 24 | 26 | 24 | 25 | 27 | 27 | 27 | 28 | 28 | 27 | 29 | 30 |
| Gross profit | 55 | 57 | 58 | 60 | 62 | 67 | 68 | 70 | 73 | 79 | 76 | 80 |
| 58 | 60 | 61 | 61 | 64 | 66 | 66 | 67 | 70 | 74 | 72 | 75 | |
| Research & development | 25 | 27 | 27 | 26 | 27 | 28 | 29 | 29 | 31 | 33 | 32 | 32 |
| Selling, general & administrative | 33 | 33 | 34 | 35 | 37 | 38 | 37 | 38 | 38 | 41 | 40 | 43 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | −3 | −3 | −2 | −1 | −2 | 1 | 2 | 3 | 3 | 5 | 4 | 5 |
| 6 | −3 | 1 | 1 | 0 | −1 | 2 | −1 | −2 | −1 | −2 | 0 | |
| Interest income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −6 | 3 | −1 | −1 | 0 | 1 | −2 | 1 | 1 | 1 | 2 | 0 |
| Income before tax | 4 | −6 | −2 | −1 | −2 | 0 | 4 | 1 | 2 | 4 | 3 | 5 |
| Income tax expense | −3 | −4 | 2 | 0 | 1 | 0 | 4 | −1 | 5 | −1 | 5 | 0 |
| Net income from continuing operations | 6 | −2 | −4 | −1 | −3 | 0 | 0 | 3 | −3 | 5 | −2 | 5 |
| Net income | 5 | −3 | −5 | −2 | −4 | −1 | −1 | 1 | −5 | 4 | −3 | 4 |
| EPS, basic | $0.07 | −$0.04 | −$0.07 | −$0.03 | −$0.05 | −$0.02 | −$0.01 | $0.02 | −$0.07 | $0.05 | −$0.04 | $0.06 |
| EPS, diluted | $0.07 | −$0.04 | −$0.07 | −$0.03 | −$0.05 | −$0.02 | −$0.01 | $0.02 | −$0.07 | $0.05 | −$0.04 | $0.06 |
| Weighted average shares, basic | 70 | 71 | 71 | 72 | 72 | 72 | 72 | 73 | 70 | 73 | 73 | 73 |
| Weighted average shares, diluted | 71 | 71 | 71 | 72 | 72 | 72 | 72 | 74 | 73 | 75 | 73 | 73 |
| EBITDA | 7 | −6 | 2 | 3 | 1 | 3 | 7 | 4 | 5 | 7 | 6 | 7 |
| Depreciation & amortization | 3 | 0 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBIT | 4 | −6 | −2 | −1 | −2 | 0 | 4 | 1 | 2 | 4 | 3 | 5 |